Molecular Insight Pharmaceuticals is Pharmaceuticals in United States that focus on critical unmet business. Founded in 1998. They cover business area such as developer, small-molecule chemistry platform, man, prostate cancer, clinical stage specialty, critical unmet diagnostic and therapeutic need.
1998
( 26 years old in 2024 )
Critical Unmet
-
160 Second Street
Cambridge, MA 02142
United States
Private
developersmall-molecule chemistry platformmanprostate cancerclinical stage specialtycritical unmet diagnostic and therapeutic need
* We use standard office opening hours in near Molecular Insight Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Molecular Insight Pharmaceuticals is Pharmaceuticals business from United States that founded in 1998 (26 years old in 2024), Molecular Insight Pharmaceuticals business is focusing on Critical Unmet.
Molecular Insight Pharmaceuticals headquarter office and corporate office address is located in 160 Second Street Cambridge, MA 02142 United States.
Molecular Insight Pharmaceuticals was founded in United States.
In 2024, Molecular Insight Pharmaceuticals is currently focus on critical unmet sector.
Above is snippet of Google Trends for "critical unmet" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Molecular Insight Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
